89bio, Inc. Operating Lease, Payments, Use
89bio, Inc. reported Operating Lease, Payments, Use of $774.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePaymentsUse · last filed 2025-02-27
- 89bio, Inc. operating lease, payments, use for the quarter ending 2024-12-31 was $268.00K, a 482.61% increase year-over-year.
- 89bio, Inc. operating lease, payments, use for the quarter ending 2024-09-30 was $267.00K, a 480.43% increase year-over-year.
- 89bio, Inc. operating lease, payments, use for the quarter ending 2024-06-30 was $193.00K, a 319.57% increase year-over-year.
- 89bio, Inc. operating lease, payments, use for the quarter ending 2024-03-31 was $46.00K, a 2.13% decline year-over-year.
- 89bio, Inc. operating lease, payments, use for fiscal 2024 was $774.00K, a 318.38% increase from fiscal 2023.
- 89bio, Inc. operating lease, payments, use for fiscal 2023 was $185.00K, a 20.94% decline from fiscal 2022.
- 89bio, Inc. operating lease, payments, use for fiscal 2022 was $234.00K.
| Period end | Operating Lease, Payments, Use 3 month | Operating Lease, Payments, Use 6 month | Operating Lease, Payments, Use 9 month | Operating Lease, Payments, Use 12 month |
|---|---|---|---|---|
| 2024-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $535.00K derived: sum of 2 quarters · filed 2025-02-27 | $728.00K derived: sum of 3 quarters · filed 2025-02-27 | $774.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $460.00K derived: sum of 2 quarters · filed 2024-11-07 | $506.00K 10-Q · filed 2024-11-07 | $552.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $239.00K 10-Q · filed 2024-08-05 | $285.00K derived: sum of 3 quarters · filed 2025-02-27 | $331.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | $46.00K 10-Q · filed 2024-05-09 | $92.00K derived: sum of 2 quarters · filed 2025-02-27 | $138.00K derived: sum of 3 quarters · filed 2025-02-27 | $184.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $92.00K derived: sum of 2 quarters · filed 2025-02-27 | $138.00K derived: sum of 3 quarters · filed 2025-02-27 | $185.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $92.00K derived: sum of 2 quarters · filed 2024-11-07 | $139.00K 10-Q · filed 2024-11-07 | $186.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $93.00K 10-Q · filed 2024-08-05 | $140.00K derived: sum of 3 quarters · filed 2025-02-27 | $200.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $47.00K 10-Q · filed 2024-05-09 | $94.00K derived: sum of 2 quarters · filed 2025-02-27 | $154.00K derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $107.00K derived: sum of 2 quarters · filed 2025-02-27 | $234.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $187.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $127.00K 10-Q · filed 2023-08-09 |